FDA Inspection 1102871 — Naveed Razzaque, MD
The FDA completed an inspection of Naveed Razzaque, MD on September 25, 2019 in Bridgeton, MO. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bridgeton, MO (United States)
Additional Details
Clinical Investigator (CI)